Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum
- PMID: 23746459
- DOI: 10.1016/j.tins.2013.04.010
Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum
Abstract
An expanded G4C2 hexanucleotide repeat in the proximal regulatory region of C9orf72 is a frequent cause of neurodegenerative diseases in the frontotemporal lobar degeneration (FTLD) and motor neuron disease (MND) spectrum. Although primarily characterized by variably abundant pathological inclusions of TDP-43 protein, the lesion load was extended to TDP-43-negative, p62-positive neuronal and glial inclusions in extended regions of the central nervous system (CNS), particularly in cerebellum, where they may be characteristic of a C9orf72 repeat expansion. Disease mechanisms associated with repeat expansion disorders, including haploinsufficiency, RNA toxicity, and abnormal translation of expanded repeat sequences, are beginning to emerge. We review genetic, clinical, and pathological highlights and discuss current insights into the biology of this novel type of repeat expansion disease.
Keywords: C9orf72; TDP43-proteinopathy; amyotrophic lateral sclerosis; frontotemporal lobar degeneration; neurodegeneration; repeat expansion diseases.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.Acta Neuropathol. 2011 Dec;122(6):691-702. doi: 10.1007/s00401-011-0911-2. Epub 2011 Nov 19. Acta Neuropathol. 2011. PMID: 22101323
-
Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.Neurobiol Aging. 2014 Oct;35(10):2421.e1-2421.e12. doi: 10.1016/j.neurobiolaging.2014.04.015. Epub 2014 Apr 19. Neurobiol Aging. 2014. PMID: 24836899 Review.
-
The neuropathology associated with repeat expansions in the C9ORF72 gene.Acta Neuropathol. 2014 Mar;127(3):347-57. doi: 10.1007/s00401-013-1232-4. Epub 2013 Dec 20. Acta Neuropathol. 2014. PMID: 24356984 Review.
-
Drosha inclusions are new components of dipeptide-repeat protein aggregates in FTLD-TDP and ALS C9orf72 expansion cases.J Neuropathol Exp Neurol. 2015 Apr;74(4):380-7. doi: 10.1097/NEN.0000000000000182. J Neuropathol Exp Neurol. 2015. PMID: 25756586 Free PMC article.
-
The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.Science. 2013 Mar 15;339(6125):1335-8. doi: 10.1126/science.1232927. Epub 2013 Feb 7. Science. 2013. PMID: 23393093
Cited by
-
Cognitive Profile of C9orf72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.Curr Neurol Neurosci Rep. 2015 Sep;15(9):59. doi: 10.1007/s11910-015-0582-9. Curr Neurol Neurosci Rep. 2015. PMID: 26198888 Review.
-
Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders.Hum Mol Genet. 2013 Oct 15;22(R1):R77-87. doi: 10.1093/hmg/ddt349. Epub 2013 Jul 29. Hum Mol Genet. 2013. PMID: 23900071 Free PMC article. Review.
-
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.Acta Neuropathol. 2014 Mar;127(3):407-18. doi: 10.1007/s00401-013-1239-x. Epub 2014 Jan 19. Acta Neuropathol. 2014. PMID: 24442578 Free PMC article.
-
Upregulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis.Dis Model Mech. 2017 May 1;10(5):551-558. doi: 10.1242/dmm.028373. Epub 2017 Jan 9. Dis Model Mech. 2017. PMID: 28069688 Free PMC article.
-
Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years.JAMA Neurol. 2018 Feb 1;75(2):236-245. doi: 10.1001/jamaneurol.2017.4266. JAMA Neurol. 2018. PMID: 29197216 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous